Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Thoracic Surgery

Free Subscription Articles published in Lancet Retrieve available abstracts of 57 articles: HTML format

Single Articles

December 2025
1. KEDHI E, Hermanides RS, Dambrink JE, Singh SK, et al
   TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and c
   Lancet. 2025;404:2593-2602.
   PubMed     Abstract available
   
   
   October 2024
2. ANDERSEN BK, Sejr-Hansen M, Maillard L, Campo G, et al
   Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial.
   Lancet. 2024 Oct 29:S0140-6736(24)02175-5. doi: 10.1016/S0140-6736(24)02175.
   PubMed     Abstract available
   
   
   
3. BECKER LM, Swaans MJ
   Present and future of functional measurements in coronary revascularisation.
   Lancet. 2024 Oct 29:S0140-6736(24)02367-5. doi: 10.1016/S0140-6736(24)02367.
   PubMed    
   
   
   
4. ERLINGE D, Andersson J, Frobert O, Tornerud M, et al
   Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial.
   Lancet. 2024 Oct 25:S0140-6736(24)02227-X. doi: 10.1016/S0140-6736(24)02227.
   PubMed     Abstract available
   
   
   
5. CAPODANNO D
   Coronary stenting with bioadaptors.
   Lancet. 2024 Oct 25:S0140-6736(24)02359-6. doi: 10.1016/S0140-6736(24)02359.
   PubMed    
   
   
   
6. ZACHARIAS J, Pitsis A, Glauber M, Solinas M, et al
   Endoscopic cardiac surgery: the path less taken.
   Lancet. 2024 Oct 1:S0140-6736(24)02080-4. doi: 10.1016/S0140-6736(24)02080.
   PubMed    
   
   
   August 2024
7. HONG SJ, Lee SJ, Lee SH, Lee JY, et al
   Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
   Lancet. 2024 Aug 30:S0140-6736(24)01454-5. doi: 10.1016/S0140-6736(24)01454.
   PubMed     Abstract available
   
   
   
8. MAMAS MA, Mintz GS
   Optical coherence tomography imaging for complex percutaneous coronary intervention.
   Lancet. 2024 Aug 30:S0140-6736(24)01593-9. doi: 10.1016/S0140-6736(24)01593.
   PubMed    
   
   
   
9. GAO C, He X, Ouyang F, Zhang Z, et al
   Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial.
   Lancet. 2024 Aug 30:S0140-6736(24)01594-0. doi: 10.1016/S0140-6736(24)01594.
   PubMed     Abstract available
   
   
   
10. REGA F, Lebreton G, Para M, Michel S, et al
    Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial.
    Lancet. 2024;404:670-682.
    PubMed     Abstract available
    
    
    
11. KITTLESON MM
    Extending the boundaries of organ preservation: hope for heart transplantation.
    Lancet. 2024;404:631-633.
    PubMed    
    
    
    June 2024
12. AKODAD M, Gall E
    New-generation Myval transcatheter heart valve in severe aortic stenosis.
    Lancet. 2024;403:2664-2665.
    PubMed    
    
    
    
13. MOHIUDDIN MM, Tully A, Singh AK, Galindo J, et al
    Possible causes of graft dysfunction in cardiac xenotransplantation - Authors' reply.
    Lancet. 2024;403:2594-2595.
    PubMed    
    
    
    
14. AI HS, Lei Y, Hu K
    Possible causes of graft dysfunction in cardiac xenotransplantation.
    Lancet. 2024;403:2593-2594.
    PubMed    
    
    
    May 2024
15. BAUMBACH A, van Royen N, Amat-Santos IJ, Hudec M, et al
    LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
    Lancet. 2024 May 22:S0140-6736(24)00821-3. doi: 10.1016/S0140-6736(24)00821.
    PubMed     Abstract available
    
    
    April 2024
16. PRAZ F, Beyersdorf F, Haugaa K, Prendergast B, et al
    Valvular heart disease: from mechanisms to management.
    Lancet. 2024;403:1576-1589.
    PubMed     Abstract available
    
    
    
17. HAHN RT, Muraru D, Lindman BR, Delgado V, et al
    Heart valve disease: at the threshold of a new era in patient management.
    Lancet. 2024;403:1519-1522.
    PubMed    
    
    
    
18. LI X, Ge Z, Kan J, Anjum M, et al
    Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282.
    PubMed     Abstract available
    
    
    
19. DEN DEKKER WK
    Is intravascular imaging the future of percutaneous coronary intervention?
    Lancet. 2024 Apr 5:S0140-6736(24)00430-6. doi: 10.1016/S0140-6736(24)00430.
    PubMed    
    
    
    
20. GE Z, Kan J, Gao X, Raza A, et al
    Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473.
    PubMed     Abstract available
    
    
    
21. PARK SJ, Ahn JM, Kang DY, Yun SC, et al
    Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
    Lancet. 2024 Apr 4:S0140-6736(24)00413-6. doi: 10.1016/S0140-6736(24)00413.
    PubMed     Abstract available
    
    
    
22. BOROVAC JA
    Percutaneous coronary intervention for non-obstructive vulnerable plaques.
    Lancet. 2024 Apr 4:S0140-6736(24)00488-4. doi: 10.1016/S0140-6736(24)00488.
    PubMed    
    
    
    March 2024
23. WERNLY B, Jung C
    Transfemoral transcatheter aortic valve replacement for pure aortic regurgitation.
    Lancet. 2024 Mar 26:S0140-6736(24)00062-X. doi: 10.1016/S0140-6736(24)00062.
    PubMed    
    
    
    
24. VAHL TP, Thourani VH, Makkar RR, Hamid N, et al
    Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.
    Lancet. 2024 Mar 26:S0140-6736(23)02806-4. doi: 10.1016/S0140-6736(23)02806.
    PubMed     Abstract available
    
    
    
25. LEBRETON G, Leprince P
    Successful heart transplant after 12 h preservation aboard a commercial flight.
    Lancet. 2024;403:1019.
    PubMed    
    
    
    February 2024
26. LEE ZS, Ryan N
    Intravascular imaging in percutaneous coronary intervention.
    Lancet. 2024 Feb 21:S0140-6736(23)02686-7. doi: 10.1016/S0140-6736(23)02686.
    PubMed    
    
    
    January 2024
27. LANDI A, Pedrazzini G, Wild L, Beele A, et al
    Coronary embolisation of native aortic valve debris during transcatheter aortic valve replacement: mechanical embolectomy and histopathological analysis.
    Lancet. 2024;403:e5-e6.
    PubMed    
    
    
    December 2023
28. JIMENEZ DIAZ VA, Iniguez Romo A
    Intracoronary artery visualisation of crystalline sirolimus deposits after drug-coated balloon angioplasty for acute coronary syndrome.
    Lancet. 2023;402:2111-2112.
    PubMed    
    
    
    November 2023
29. MESSAS E, Ijsselmuiden A, Trifunovic-Zamaklar D, Cholley B, et al
    Treatment of severe symptomatic aortic valve stenosis using non-invasive ultrasound therapy: a cohort study.
    Lancet. 2023 Nov 13:S0140-6736(23)01518-0. doi: 10.1016/S0140-6736(23)01518.
    PubMed     Abstract available
    
    
    
30. DI MARIO C, Mattesini A
    Non-invasive high-energy ultrasound: alternative treatment before transcatheter aortic valve implantation?
    Lancet. 2023 Nov 13:S0140-6736(23)02186-4. doi: 10.1016/S0140-6736(23)02186.
    PubMed    
    
    
    October 2023
31. VERHEMEL S, Van Mieghem NM
    Revalving to treat transcatheter valve failure.
    Lancet. 2023;402:1500-1501.
    PubMed    
    
    
    
32. KHO SS, Chai CS, Ho RL, Ismail AM, et al
    Pulmonary alveolar microlithiasis-a rare lung disease-diagnosed by transbronchial cryobiopsy.
    Lancet. 2023;402:1356.
    PubMed    
    
    
    August 2023
33. MAKKAR RR, Kapadia S, Chakravarty T, Cubeddu RJ, et al
    Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study.
    Lancet. 2023 Aug 31:S0140-6736(23)01636-7. doi: 10.1016/S0140-6736(23)01636.
    PubMed     Abstract available
    
    
    
34. CONEN D, Ke Wang M, Popova E, Chan MTV, et al
    Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial.
    Lancet. 2023 Aug 25:S0140-6736(23)01689-6. doi: 10.1016/S0140-6736(23)01689.
    PubMed     Abstract available
    
    
    May 2023
35. BRADBURY AW, Moakes CA, Popplewell M, Meecham L, et al
    A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisatio
    Lancet. 2023;401:1798-1809.
    PubMed     Abstract available
    
    
    April 2023
36. GAUDINO M, Andreotti F, Kimura T
    Current concepts in coronary artery revascularisation.
    Lancet. 2023 Apr 27:S0140-6736(23)00459-2. doi: 10.1016/S0140-6736(23)00459.
    PubMed     Abstract available
    
    
    March 2023
37. PUSTJENS TFS, Vriesendorp PA, Van't Hof AWJ
    Revascularisation in acute coronary syndromes: change in practice?
    Lancet. 2023 Mar 3:S0140-6736(23)00403-8. doi: 10.1016/S0140-6736(23)00403.
    PubMed    
    
    
    November 2022
38. LI Y, Liang Z, Qin L, Wang M, et al
    Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)01999.
    PubMed     Abstract available
    
    
    July 2022
39. MAHMOOD F, Topol EJ
    Digitising heart transplant rejection.
    Lancet. 2022;400:17.
    PubMed    
    
    
    April 2022
40. SAJI H, Okada M, Tsuboi M, Nakajima R, et al
    Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
    Lancet. 2022;399:1607-1617.
    PubMed     Abstract available
    
    
    
41. LICHT PB
    When less is more in thoracic surgery.
    Lancet. 2022;399:1574-1575.
    PubMed    
    
    
    
42. SEKULIC SP, Sekulic M
    Atypical arrhythmogenic presentation of giant cell myocarditis diagnosed after heart transplant.
    Lancet. 2022;399:1411.
    PubMed    
    
    
    
43. BORGES FK, Spence J
    Challenging dogma about perioperative warming during non-cardiac surgery.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00607.
    PubMed    
    
    
    
44. SESSLER DI, Pei L, Li K, Cui S, et al
    Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00560.
    PubMed     Abstract available
    
    
    February 2022
45. THEODOROPOULOS KC, Liakopoulou A, Tsagkaropoulos S, Kassimis G, et al
    Under-sensing by a temporary pacemaker after cardiac surgery and ventricular fibrillation.
    Lancet. 2022;399:677.
    PubMed    
    
    
    
46. BODEN WE, Kaski JC, Al-Lamee R, Weintraub WS, et al
    What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
    Lancet. 2022;399:691-694.
    PubMed    
    
    
    January 2022
47. BURKI T
    Pig-heart transplantation surgeons look to the next steps.
    Lancet. 2022;399:347.
    PubMed    
    
    
    November 2021
48. SABATINE MS, Bergmark BA, Murphy SA, O'Gara PT, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02334.
    PubMed     Abstract available
    
    
    
49. MEHRAN R, Owen R, Chiarito M, Baber U, et al
    A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02326.
    PubMed     Abstract available
    
    
    
50. GAUDINO M, Sanna T, Ballman KV, Robinson NB, et al
    Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02490.
    PubMed     Abstract available
    
    
    
51. BELLEY-COTE EP, Devereaux PJ
    PCI versus CABG for left main coronary artery disease: is the jury still out?
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02491.
    PubMed    
    
    
    
52. VAN BOVEN WJ, de Groot JR, Kluin J
    A short cut to prevent postoperative atrial fibrillation.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02435.
    PubMed    
    
    
    
53. KANG J, Koo BK, Park KW, Shin ES, et al
    Aspirin versus clopidogrel after percutaneous coronary intervention - Authors' reply.
    Lancet. 2021;398:1685-1686.
    PubMed    
    
    
    
54. PAREEK M, Byrne C
    Aspirin versus clopidogrel after percutaneous coronary intervention.
    Lancet. 2021;398:1685.
    PubMed    
    
    
    
55. BYRNE RA, McGovern L
    Angiography-derived quantitative flow ratio guidance of coronary intervention: measure twice, cut once.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02397.
    PubMed    
    
    
    
56. XU B, Tu S, Song L, Jin Z, et al
    Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02248.
    PubMed     Abstract available
    
    
    October 2021
57. KIM CJ, Park MW, Kim MC, Choo EH, et al
    Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised tr
    Lancet. 2021;398:1305-1316.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge.